Teresa De Marco, MD
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in San Francisco, California, trained at University of Chicago, Pritzker School of Medicine (class of 1982). Their prescriptions cost Medicare Part D more than their services did: $2,158,289 for 697 claims, against $39,521 paid for services in 2024. Boston Scientific Corporation was the largest of 8 companies reporting payments in 2025, $86,417 in all, mostly consulting fees.
Overview
| NPI | 1669420956 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | May 5, 2006 |
| Last updated in NPPES | Oct 12, 2017 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | G52404 | CA |
| Internal Medicine | 207R00000X | G52404 | CA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | G52404 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 122 |
|---|---|
| Services billed | 1,048 across 16 procedure codes |
| Paid by Medicare | $39,521 |
Part D prescriptions in 2024
| Prescriptions (claims) | 697 · 1,261 30-day fills |
|---|---|
| Patients | 71 |
| Total drug cost | $2,158,289 |
| Generic share | 71% of claims |
Education and affiliations
| Medical school | University of Chicago, Pritzker School of Medicine |
|---|---|
| Graduation year | 1982 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical groups
- University of California San FranciscoSan Francisco, CA · 1,839 clinicians
- UCSF Medical Group Business ServicesSan Francisco, CA · 1,598 clinicians
- Regents of the University of CaliforniaSan Francisco, CA · 732 clinicians
Hospital affiliation
- UCSF Medical CenterSan Francisco, CA
Industry payments (Open Payments)
- 2025$86,417 · 43 payments from 8 companies
- 2024$88,208 · 60 payments from 7 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Boston Scientific Corporation | $36,450 | 26 |
| Alexion Pharmaceuticals, Inc. | $35,200 | 5 |
| Sanofi US Services Inc. | $9,000 | 6 |
| Merck Sharp & Dohme LLC | $5,340 | 2 |
| United Therapeutics Corporation | $127.00 | 1 |
What the 2025 payments were for
- Consulting Fee$85,990 · 39 payments
- Food and Beverage$427.25 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in San Francisco
- 1720377146
- 1861811044
- 1003254186
- 1699207217
- 1942162144
- 1386873370
- 1184959272
- 1235199340
- 1699113407
- 1942437470
- 1184157323
- 1194735019
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →